Print Page  Close Window

SEC Filings

VITAE PHARMACEUTICALS, INC filed this Form S-1/A on 08/28/2014
Entire Document


(t)                                    Plan” shall mean the Vitae Pharmaceuticals, Inc. 2001 Stock Plan, as in effect on the Date of Grant.


(u)                                 Purchase Price” shall mean the Exercise Price multiplied by the number of Option Shares with respect to which this option is being exercised.


(v)                                 Right of First Refusal” shall mean the Company’s right of first refusal described in Section 7.


(w)                               Securities Act” shall mean the Securities Act of 1933, as amended.


(x)                                 Service” shall mean service as an Employee, Outside Director or Consultant.


(y)                                 Share” shall mean one share of Stock, as adjusted in accordance with Section 8 of the Plan (if applicable).


(z)                                  Stock” shall mean the Common Stock of the Company.


(aa)                          Subsidiary” shall mean any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company, if each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.


(bb)                          Transferee” shall mean any person to whom the Optionee has directly or indirectly transferred any Share acquired under this Agreement.


(cc)                            Transfer Notice” shall mean the notice of a proposed transfer of Shares described in Section 7.